Home

DAVID J BRAILER

CIK 1222879 · EVP & Chief Health Officer · last filed 2025-09-03

DAVID J BRAILER is an EVP & Chief Health Officer who has filed 62 SEC Form 4 insider transactions across 3 companies since 2010. The most recent filing shows the insider had shares withheld for taxes covering $87.2K of CI on Sep 3, 2025. Current disclosed insider exposure totals $5.0M across reported positions. 38 SEC filings were submitted jointly with Walgreens Boots Alliance, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.95M

Companies

3

Total Filings

62

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
4 PRESIDIO TERRACE
SAN FRANCISCO, CA 94118
Related Filers
Walgreens Boots Alliance, Inc. — 38 joint filings, latest 2022-07-15
CO WALGREEN — 18 joint filings, latest 2014-11-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CI EVP & Chief Health Officer 17,525 $282.52 $4.95M $0 8 2025-09-03
Walgreens Boots Alliance, Inc. (WBA) Delisted Director — $11.98 — $0 38 2022-07-15
WALGREEN CO (WAG) Delisted Director 5,167 — — $0 16 2014-11-03

Recent Filings

62 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-09-03 CI Tax (F) −290 -$87.2K EDGAR
2025-03-04 CI Mixed +8,773 -$1.04M EDGAR
2024-09-04 CI Tax (F) −290 -$104.8K EDGAR
2024-03-05 CI Mixed +1,269 -$503.7K EDGAR
2024-03-01 CI Grant (A) +3,121 $0 EDGAR
2023-09-05 CI Tax (F) −202 -$56.2K EDGAR
2023-02-24 CI Grant (A) +3,395 $0 EDGAR
2022-09-06 CI Grant (A) +1,749 $0 EDGAR
2022-07-15 Walgreens Boots Alliance, Inc. (WBA) Delisted Grant (A) — $0 EDGAR
2022-05-02 Walgreens Boots Alliance, Inc. (WBA) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 62
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.